[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Rastinejad et al., 2015 - Google Patents

Nuclear receptor full-length architectures: confronting myth and illusion with high resolution

Rastinejad et al., 2015

View HTML
Document ID
12469916888345192189
Author
Rastinejad F
Ollendorff V
Polikarpov I
Publication year
Publication venue
Trends in biochemical sciences

External Links

Snippet

The crystal structures of three nuclear receptor (NR) complexes have emerged to reveal their multidomain architectures on DNA. These pictures provide unprecedented views of interfacial couplings between the DNA-binding domains (DBDs) and ligand-binding …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8665—Signal analysis for calibrating the measuring apparatus

Similar Documents

Publication Publication Date Title
Rastinejad et al. Nuclear receptor full-length architectures: confronting myth and illusion with high resolution
Chandra et al. The quaternary architecture of RARβ–RXRα heterodimer facilitates domain–domain signal transmission
Nadal et al. Structure of the homodimeric androgen receptor ligand-binding domain
Chalmers et al. Differential hydrogen/deuterium exchange mass spectrometry analysis of protein–ligand interactions
Regan et al. Structural mechanism of functional modulation by gene splicing in NMDA receptors
de Vera et al. Synergistic regulation of coregulator/nuclear receptor interaction by ligand and DNA
Chrisman et al. Defining a conformational ensemble that directs activation of PPARγ
Edman et al. Ligand binding mechanism in steroid receptors: from conserved plasticity to differential evolutionary constraints
Verhalen et al. Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein
Brust et al. A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
Van Drie et al. Cryo-EM as a powerful tool for drug discovery
Robertson et al. Drug discovery in the era of cryo-electron microscopy
Nettles et al. Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors
Margeta-Mitrovic et al. A trafficking checkpoint controls GABAB receptor heterodimerization
de Vera et al. Defining a canonical ligand-binding pocket in the orphan nuclear receptor Nurr1
Hughes et al. Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism
Sun et al. Structural insights into human acid-sensing ion channel 1a inhibition by snake toxin mambalgin1
Stehlin-Gaon et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ
Gulezian et al. Membrane protein production and formulation for drug discovery
Xu et al. Crystal structures of Lgr4 and its complex with R-spondin1
Matulef et al. Individual ion binding sites in the K+ channel play distinct roles in C-type inactivation and in recovery from inactivation
Diao et al. Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
Putcha et al. Structural basis for negative cooperativity within agonist-bound TR: RXR heterodimers
Heidari et al. Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
Sexton et al. To bind or not to bind: unravelling GPCR polypharmacology